Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Sl, Vinall"'
Autor:
Xue L, Fergusson J, Salimi M, Panse I, Je, Ussher, Ahmed N. Hegazy, Sl, Vinall, Dg, Jackson, Mg, Hunter, Pettipher R, Ogg G, Klenerman P
Publikováno v:
Europe PubMed Central
The Journal of Allergy and Clinical Immunology
The Journal of Allergy and Clinical Immunology
BACKGROUND: Prostaglandin D2 (PGD2) and cysteinyl leukotrienes (cysLTs) are lipid mediators derived from mast cells, which activate TH2 cells. The combination of PGD2 and cysLTs (notably cysteinyl leukotriene E4 [LTE4]) enhances TH2 cytokine producti
Autor:
Xue L; Oxford NIHR Biomedical Research Centre, Translational Immunology Laboratory, Nuffield Department of Medicine, John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom; Respiratory Medicine Unit, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom. Electronic address: luzheng.xue@ndm.ox.ac.uk., Fergusson J; Peter Medawar Building for Pathogen Research, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom., Salimi M; Oxford NIHR Biomedical Research Centre, Translational Immunology Laboratory, Nuffield Department of Medicine, John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom; MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom., Panse I; Oxford NIHR Biomedical Research Centre, Translational Immunology Laboratory, Nuffield Department of Medicine, John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom., Ussher JE; Peter Medawar Building for Pathogen Research, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom., Hegazy AN; Translational Gastroenterology Unit, Nuffield Department of Medicine, John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom., Vinall SL; Atopix Therapeutics Limited, Abingdon, United Kingdom., Jackson DG; MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom., Hunter MG; Atopix Therapeutics Limited, Abingdon, United Kingdom., Pettipher R; Atopix Therapeutics Limited, Abingdon, United Kingdom., Ogg G; Oxford NIHR Biomedical Research Centre, Translational Immunology Laboratory, Nuffield Department of Medicine, John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom; MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom., Klenerman P; Oxford NIHR Biomedical Research Centre, Translational Immunology Laboratory, Nuffield Department of Medicine, John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom; Peter Medawar Building for Pathogen Research, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
Publikováno v:
The Journal of allergy and clinical immunology [J Allergy Clin Immunol] 2015 May; Vol. 135 (5), pp. 1358-66.e1-11. Date of Electronic Publication: 2014 Oct 19.
Autor:
Pettipher R; Oxagen Ltd, 91 Milton Park, Abingdon, Oxon, OX14 4RY, United Kingdom. r.pettipher@oxagen.co.uk, Vinall SL, Xue L, Speight G, Townsend ER, Gazi L, Whelan CJ, Armer RE, Payton MA, Hunter MG
Publikováno v:
The Journal of pharmacology and experimental therapeutics [J Pharmacol Exp Ther] 2012 Feb; Vol. 340 (2), pp. 473-82. Date of Electronic Publication: 2011 Nov 21.
Autor:
Pérez-Novo CA; Upper Airways Research Laboratory, Department of Otorhinolaryngology, Ghent University Hospital, Ghent, Belgium., Holtappels G, Vinall SL, Xue L, Zhang N, Bachert C, Pettipher R
Publikováno v:
Allergy [Allergy] 2010 Mar; Vol. 65 (3), pp. 304-10. Date of Electronic Publication: 2009 Oct 12.
Autor:
Vinall SL; Department of Drug Discovery, Oxagen Ltd, Abingdon, Oxon, United Kingdom., Townsend ER, Pettipher R
Publikováno v:
Immunology [Immunology] 2007 Aug; Vol. 121 (4), pp. 577-84. Date of Electronic Publication: 2007 Apr 16.